241 related articles for article (PubMed ID: 25187265)
21. Platelet actin nodules are podosome-like structures dependent on Wiskott-Aldrich syndrome protein and ARP2/3 complex.
Poulter NS; Pollitt AY; Davies A; Malinova D; Nash GB; Hannon MJ; Pikramenou Z; Rappoport JZ; Hartwig JH; Owen DM; Thrasher AJ; Watson SP; Thomas SG
Nat Commun; 2015 Jun; 6():7254. PubMed ID: 26028144
[TBL] [Abstract][Full Text] [Related]
22. WASP is involved in proliferation and differentiation of human haemopoietic progenitors in vitro.
Kajiwara M; Nonoyama S; Eguchi M; Morio T; Imai K; Okawa H; Kaneko M; Sako M; Ohga S; Maeda M; Hibi S; Hashimito H; Shibuya A; Ochs HD; Nakahata T; Yata JI
Br J Haematol; 1999 Nov; 107(2):254-62. PubMed ID: 10583210
[TBL] [Abstract][Full Text] [Related]
23. New Structural Insights into Formation of the Key Actin Regulating WIP-WASp Complex Determined by NMR and Molecular Imaging.
Halle-Bikovski A; Fried S; Rozentur-Shkop E; Biber G; Shaked H; Joseph N; Barda-Saad M; Chill JH
ACS Chem Biol; 2018 Jan; 13(1):100-109. PubMed ID: 29215267
[TBL] [Abstract][Full Text] [Related]
24. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein.
Stewart DM; Tian L; Nelson DL
J Immunol; 1999 Apr; 162(8):5019-24. PubMed ID: 10202051
[TBL] [Abstract][Full Text] [Related]
25. Wiskott-Aldrich Syndrome in four male siblings from a consanguineous family from Lebanon.
Mansour R; El-Orfali Y; Saber A; Noun D; Youssef N; Youssef Y; Hanna-Wakim R; Dbaibo G; Abboud M; Massaad MJ
Clin Immunol; 2020 Oct; 219():108573. PubMed ID: 32814211
[TBL] [Abstract][Full Text] [Related]
26. The Wiskott-Aldrich syndrome.
Orange JS; Stone KD; Turvey SE; Krzewski K
Cell Mol Life Sci; 2004 Sep; 61(18):2361-85. PubMed ID: 15378206
[TBL] [Abstract][Full Text] [Related]
27. WASP-interacting protein (WIP): working in polymerisation and much more.
Antón IM; Jones GE; Wandosell F; Geha R; Ramesh N
Trends Cell Biol; 2007 Nov; 17(11):555-62. PubMed ID: 17949983
[TBL] [Abstract][Full Text] [Related]
28. The Phenotype and Treatment of WIP Deficiency: Literature Synopsis and Review of a Patient With Pre-transplant Serial Donor Lymphocyte Infusions to Eliminate CMV.
Schwinger W; Urban C; Ulreich R; Sperl D; Karastaneva A; Strenger V; Lackner H; Boztug K; Albert MH; Benesch M; Seidel MG
Front Immunol; 2018; 9():2554. PubMed ID: 30450104
[TBL] [Abstract][Full Text] [Related]
29. WASP plays a novel role in regulating platelet responses dependent on alphaIIbbeta3 integrin outside-in signalling.
Shcherbina A; Cooley J; Lutskiy MI; Benarafa C; Gilbert GE; Remold-O'Donnell E
Br J Haematol; 2010 Feb; 148(3):416-27. PubMed ID: 19863535
[TBL] [Abstract][Full Text] [Related]
30. Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.
Prete F; Catucci M; Labrada M; Gobessi S; Castiello MC; Bonomi E; Aiuti A; Vermi W; Cancrini C; Metin A; Hambleton S; Bredius R; Notarangelo LD; van der Burg M; Kalinke U; Villa A; Benvenuti F
J Exp Med; 2013 Feb; 210(2):355-74. PubMed ID: 23337808
[TBL] [Abstract][Full Text] [Related]
31. Platelet-associated IgAs and impaired GPVI responses in platelets lacking WIP.
Falet H; Marchetti MP; Hoffmeister KM; Massaad MJ; Geha RS; Hartwig JH
Blood; 2009 Nov; 114(21):4729-37. PubMed ID: 19692704
[TBL] [Abstract][Full Text] [Related]
32. Studies of the expression of the Wiskott-Aldrich syndrome protein.
Stewart DM; Treiber-Held S; Kurman CC; Facchetti F; Notarangelo LD; Nelson DL
J Clin Invest; 1996 Jun; 97(11):2627-34. PubMed ID: 8647957
[TBL] [Abstract][Full Text] [Related]
33. The chemotactic defect in wiskott-Aldrich syndrome macrophages is due to the reduced persistence of directional protrusions.
Ishihara D; Dovas A; Park H; Isaac BM; Cox D
PLoS One; 2012; 7(1):e30033. PubMed ID: 22279563
[TBL] [Abstract][Full Text] [Related]
34. Increased uptake by splenic red pulp macrophages contributes to rapid platelet turnover in WASP(-) mice.
Prislovsky A; Strom TS
Exp Hematol; 2013 Sep; 41(9):789-98. PubMed ID: 23727585
[TBL] [Abstract][Full Text] [Related]
35. Wiskott-Aldrich syndrome caused by a new mutation associated with multifocal dermal juvenile xanthogranulomas.
Jesenak M; Plamenova I; Plank L; Banovcin P
Pediatr Dermatol; 2013; 30(5):e91-3. PubMed ID: 23157619
[TBL] [Abstract][Full Text] [Related]
36. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
Snapper SB; Rosen FS
Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
[TBL] [Abstract][Full Text] [Related]
37. WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome.
Curcio C; Pannellini T; Lanzardo S; Forni G; Musiani P; Antón IM
J Pathol; 2007 Jan; 211(1):67-75. PubMed ID: 17086554
[TBL] [Abstract][Full Text] [Related]
38. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Boztug K; Dewey RA; Klein C
Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
[TBL] [Abstract][Full Text] [Related]
39. Wiskott-Aldrich Syndrome causing mutation, Pro373Ser restricts conformational changes essential for WASP activity in T-cells.
Jain N; George B; Thanabalu T
Biochim Biophys Acta; 2014 Apr; 1842(4):623-34. PubMed ID: 24440360
[TBL] [Abstract][Full Text] [Related]
40. Triple-color FRET analysis reveals conformational changes in the WIP-WASp actin-regulating complex.
Fried S; Reicher B; Pauker MH; Eliyahu S; Matalon O; Noy E; Chill J; Barda-Saad M
Sci Signal; 2014 Jun; 7(331):ra60. PubMed ID: 24962707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
